Accumulation of the chromatin remodeling protein SMARCA4 (BRG1) leads to the loss of PRCs at Pou5f1 in mouse cells [47] and at INK4b-ARF-INK4a in human malignant rhabdoid tumor cells [48]. Here, CDKN2B is linked to rhabdoid tumor.